Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease
发布时间:
1970-01-01
Dai C, Kong B, Shuai W, Xiao Z, Qin T, Fang J, Gong Y, Zhu J, Liu Q, Fu H, Meng H, Huang H. Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease. ESC Heart Fail. 2023 Feb;10(1):578-593. doi: 10.1002/ehf2.14169. Epub 2022 Nov 11.
活动中心